These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4207315)

  • 1. Thyrotropin releasing hormone: enhancement of DOPA activity in thyroidectomized rats.
    Plotnikoff NP; Prange AJ; Breese GR; Wilson IC
    Life Sci; 1974 Apr; 14(7):1271-8. PubMed ID: 4207315
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone.
    Plotnikoff NP; Prange AJ; Breese GR; Anderson MS; Wilson IC
    Science; 1972 Oct; 178(4059):417-8. PubMed ID: 4627781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 4. Species specificity in the TSH response to the administration of L-dopa.
    Tsukui T; Kanno Y; Koizumi Y; Hashizume K; Onaya T
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):346-9. PubMed ID: 4204828
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Neurotropic effects of thyrotropin releasing hormone (TRH).
    Kruse H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R51. PubMed ID: 4276591
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of thyrotropin (TSH) bioactivity by TSH-releasing hormone and thyroid hormone.
    Menezes-Ferreira MM; Petrick PA; Weintraub BD
    Endocrinology; 1986 May; 118(5):2125-30. PubMed ID: 3084213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP; Breese GR; Prange AJ
    Pharmacol Biochem Behav; 1975; 3(4):665-70. PubMed ID: 810812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of thyroidectomy and thyroxine replacement on the responsiveness of the anterior pituitaries from male rats to thyrotropin-releasing hormone in vitro.
    Tang TK; Wang SW; Wang PS
    Experientia; 1986 Sep; 42(9):1031-4. PubMed ID: 3093263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone and thyrotropin in the control of thyroid function in the turtle, Chrysemys picta.
    Sawin CT; Bacharach P; Lance V
    Gen Comp Endocrinol; 1981 Sep; 45(1):7-11. PubMed ID: 6793449
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of L-dopa on hypothalamic-pituitary-thyroid axis in the rats].
    Tonooka N; Kobayashi I; Kobayashi S; Suzuki M
    Nihon Naibunpi Gakkai Zasshi; 1974 Jan; 50(1):30-41. PubMed ID: 4858184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of the TSH level in thyroidectomized patients after thyrotropin releasing hormone (TRH)].
    Piaszek L; Strötges MW
    Nucl Med (Stuttg); 1976 Feb; 15(1):43-5. PubMed ID: 815889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone stimulated pituitary and thyroid gland responsiveness and 3,5,3'-triiodothyronine suppression in fetal and neonatal lambs.
    Klein AH; Fisher DA
    Endocrinology; 1980 Mar; 106(3):697-701. PubMed ID: 6766384
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone.
    Duntas L; Roussel JP; Astier H; Keck FS; Rosenthal J; Pfeiffer EF
    Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    Samaan NA; Beceiro JR; Hill CS; Haynie TP; Glenn HJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):438-43. PubMed ID: 4626272
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent abnormalities in pituitary function following neonatal thyrotoxicosis in the rat.
    Azizi F; Vagenakis AG; Bollinger J; Reichlin S; Braverman LE; Ingbar SH
    Endocrinology; 1974 Jun; 94(6):1681-8. PubMed ID: 4208653
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Effects of long term administration of thyrotropin-releasing hormone in the baboon (author's transl)].
    Jaquet P; Jaquet C; Carayon P; Strauch G
    Ann Endocrinol (Paris); 1974; 35(5):581-2. PubMed ID: 4219112
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to orally administered synthetic thyrotropin-releasing hormone in man.
    Haigler ED; Hershman JM; Pittman JA
    J Clin Endocrinol Metab; 1972 Nov; 35(5):631-5. PubMed ID: 4627201
    [No Abstract]   [Full Text] [Related]  

  • 19. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
    Azizi F; Vagenakis AG; Portnay GI; Rapoport B; Ingbar SH; Braverman LE
    N Engl J Med; 1975 Feb; 292(6):273-7. PubMed ID: 803298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of serum thyrotropin (TSH) by L-dopa in chronic hypothyroidism: interrelationships in the regulation of TSH and prolactin secretion.
    Rapoport B; Refetoff S; Fang VS; Friesen HG
    J Clin Endocrinol Metab; 1973 Feb; 36(2):256-62. PubMed ID: 4630270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.